Scholarlink

Background <p>Local treatment of pelvic Ewing Sarcoma (EWS) is czhallenging due to complex anatomy and potential complications. Local therapy may be deferred to maintain chemotherapy dose-intensity, but the impact of this delay on outcomes remains unclear.</p> Methods <p>A systematic review using the PICO model evaluated whether delayed local therapy affects long-term outcomes in localized pelvic EWS. Ovid Medline, Ovid Embase, and Cochrane Central databases were searched through June 2024. Studies were screened by two independent reviewers for quantitative and qualitative data extraction.</p> Results <p>Of 1849 studies screened, eight eligible studies including 2618 patients were identified; none were pelvic-specific. When specified, 1–18% had pelvic primaries. All studies were retrospective with substantial heterogeneity in endpoints. Seven of eight studies indicated delayed local therapy was associated with reduced event-free survival (EFS) and/or overall survival (OS). In the largest study (Lin et al.) of 1319 EWS patients, delayed local therapy &gt; 16 weeks was associated with significantly reduced OS (HR 1.41, CI 1.11–1.80, <i>p</i> = 0.005).</p> Conclusion <p> This systematic review highlights the importance of multidisciplinary coordinated care during initial chemotherapy to optimize local therapy timing, which may impact outcomes. Further studies are needed to assess timing significance, particularly for pelvic EWS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A systematic review on the impact of delayed local therapy in patients with Ewing sarcoma of the pelvis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月27日

查看全文
  • Shook Fe Yap,
  • Natacha Omer,
  • Vivek Bhadri,
  • Jeremy Lewin,
  • Wayne Nicholls,
  • Claire Carkeet,
  • Lisa Orme,
  • Marianne Phillips,
  • Mark Winstanley,
  • Smaro Lazarakis,
  • Jasmine Mar,
  • Angela Hong,
  • Julie Cayrol

摘要

Background

Local treatment of pelvic Ewing Sarcoma (EWS) is czhallenging due to complex anatomy and potential complications. Local therapy may be deferred to maintain chemotherapy dose-intensity, but the impact of this delay on outcomes remains unclear.

Methods

A systematic review using the PICO model evaluated whether delayed local therapy affects long-term outcomes in localized pelvic EWS. Ovid Medline, Ovid Embase, and Cochrane Central databases were searched through June 2024. Studies were screened by two independent reviewers for quantitative and qualitative data extraction.

Results

Of 1849 studies screened, eight eligible studies including 2618 patients were identified; none were pelvic-specific. When specified, 1–18% had pelvic primaries. All studies were retrospective with substantial heterogeneity in endpoints. Seven of eight studies indicated delayed local therapy was associated with reduced event-free survival (EFS) and/or overall survival (OS). In the largest study (Lin et al.) of 1319 EWS patients, delayed local therapy > 16 weeks was associated with significantly reduced OS (HR 1.41, CI 1.11–1.80, p = 0.005).

Conclusion

This systematic review highlights the importance of multidisciplinary coordinated care during initial chemotherapy to optimize local therapy timing, which may impact outcomes. Further studies are needed to assess timing significance, particularly for pelvic EWS.